Cited by 124Genomics and Chromatin DynamicsRNA Research and SplicingCancer-related Molecular Pathways

Interaction of Cyclin-Dependent Kinase 12/CrkRS with Cyclin K1 Is Required for the Phosphorylation of the C-Terminal Domain of RNA Polymerase II

Open access
Cheng, S.-W. Grace, Kuzyk, Michael A., Moradian, Annie, Ichu, Taka-Aki, Chang, Vicky C.-D., Tien, Jerry F., Vollett, Sarah E., Griffith, Malachi +2 more·2012·Molecular and Cellular Biology

Abstract

CrkRS (Cdc2-related kinase, Arg/Ser), or cyclin-dependent kinase 12 (CKD12), is a serine/threonine kinase believed to coordinate transcription and RNA splicing. While CDK12/CrkRS complexes were known to phosphorylate the C-terminal domain (CTD) of RNA polymerase II (RNA Pol II), the cyclin regulating this activity was not known. Using immunoprecipitation and mass spectrometry, we identified a 65-kDa isoform of cyclin K (cyclin K1) in endogenous CDK12/CrkRS protein complexes. We show that cyclin K1 complexes isolated from mammalian cells contain CDK12/CrkRS but do not contain CDK9, a presumed partner of cyclin K. Analysis of extensive RNA-Seq data shows that the 65-kDa cyclin K1 isoform is the predominantly expressed form across numerous tissue types. We also demonstrate that CDK12/CrkRS is dependent on cyclin K1 for its kinase activity and that small interfering RNA (siRNA) knockdown of CDK12/CrkRS or cyclin K1 has similar effects on the expression of a luciferase reporter gene. Our data suggest that cyclin K1 is the primary cyclin partner for CDK12/CrkRS and that cyclin K1 is required to activate CDK12/CrkRS to phosphorylate the CTD of RNA Pol II. These properties are consistent with a role of CDK12/CrkRS in regulating gene expression through phosphorylation of RNA Pol II.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/mcb.06267-11

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CDK12, a known CR8 target whose activity requires cycK, is a crucial component for CR8-induced destabilization of cycKeGFP.

    “In addition, we identified cyclin-dependent kinase 12 (CDK12), which is a known target of CR819 and whose activity depends on the interaction with cycK20, as a crucial component for CR8-induced cycKeGFP destabilisation (Fig. 1g, Extended Data Fig. 2h–k).”
  • To execute their functions, CDK12 and CDK13 form two separate complexes with CCNK.

    “To execute their functions, CDK12 and CDK13 form two separate complexes with CCNK (Blazek et al., 2011; Cheng et al., 2012).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cheng, S.-W. G., Kuzyk, M. A., Moradian, A., Ichu, T.-A., Chang, V. C.-D., Tien, J. F., Vollett, S. E., Griffith, M., Marra, M. A., & Morin, G. B.
Affiliations
BC Cancer Agency (CA)
Venue
Molecular and Cellular Biology
Published
2012-11-01
Volume
32
Issue
22
Pages
4691-4704
ISSN
  • 0270-7306 (ISSN-L)
  • 1098-5549
OpenAlex
W2109885069
Cited by
124
References
68
Citations by year
2026: 8 · 2025: 11 · 2024: 11 · 2023: 8 · 2022: 10 · 2021: 5 · 2020: 20 · 2019: 8 · 2018: 10 · 2017: 4 · 2016: 6 · 2015: 8 · 2014: 7 · 2013: 7 · 2012: 1
FWCI
2.96
Type
journal article
Language
en
Open access
Locations
  • Molecular and Cellular Biology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
Funders
BC Cancer Agency
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
RNA polymerase II C-terminal domain, CTD phosphorylation, cyclin-dependent kinases, CDK9, transcriptional regulation, RNA splicing, kinase activation, gene expression regulation
MeSH terms
Binding Sites, Gene Expression Regulation, HeLa Cells, Humans, Luciferases, Phosphorylation, Protein Binding, RNA Polymerase II, Mass Spectrometry, Signal Transduction, Cyclins, Protein Structure, Tertiary, Genes, Reporter, Cyclin-Dependent Kinases, Protein Isoforms, RNA, Small Interfering, Immunoprecipitation, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review